Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients

by Huang, Yiqing, Aminkeng, Folefac, Wong, Alvin SC, Tay, Sen Hee, Zhao, Joseph J, Ang, Yvonne, Soo, Ross A, Goh, Boon Cher
Published 2022

Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients

by Huang, Yiqing, Soon, Yu Yang, Aminkeng, Folefac, Tay, Sen Hee, Ang, Yvonne, Kee, Adrian CL, Goh, Boon Cher, Wong, Alvin SC, Soo, Ross A
Published 2022

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

by Huang, Yiqing, Zhao, Joseph J, Soon, Yu Yang, Kee, Adrian, Tay, Sen Hee, Aminkeng, Folefac, Ang, Yvonne, Wong, Alvin SC, Bharwani, Lavina D, Goh, Boon Cher, Soo, Ross A
Published 2023